HIV-1 Vif suppresses antiviral immunity by targeting STING.

HIV-1 infection-induced cGAS-STING-TBK1-IRF3 signaling activates innate immunity to produce type I interferon (IFN). The HIV-1 nonstructural protein viral infectivity factor (Vif) is essential in HIV-1 replication, as it degrades the host restriction factor APOBEC3G. However, whether and how it regulates the host immune response remains to be determined. In this study, we found that Vif inhibited the production of type I IFN to promote immune evasion. HIV-1 infection induced the activation of the host tyrosine kinase FRK, which subsequently phosphorylated the immunoreceptor tyrosine-based inhibitory motif (ITIM) of Vif and enhanced the interaction between Vif and the cellular tyrosine phosphatase SHP-1 to inhibit type I IFN. Mechanistically, the association of Vif with SHP-1 facilitated SHP-1 recruitment to STING and inhibited the K63-linked ubiquitination of STING at Lys337 by dephosphorylating STING at Tyr162. However, the FRK inhibitor D-65495 counteracted the phosphorylation of Vif to block the immune evasion of HIV-1 and antagonize infection. These findings reveal a previously unknown mechanism through which HIV-1 evades antiviral immunity via the ITIM-containing protein to inhibit the posttranslational modification of STING. These results provide a molecular basis for the development of new therapeutic strategies to treat HIV-1 infection. © 2021. The Author(s), under exclusive licence to CSI and USTC.

Citation

Yu Wang, Gui Qian, Lingyan Zhu, Zhuo Zhao, Yinan Liu, Wendong Han, Xiaokai Zhang, Yihua Zhang, Tingrong Xiong, Hao Zeng, Xianghui Yu, Xiaofang Yu, Xiaoyan Zhang, Jianqing Xu, Quanming Zou, Dapeng Yan. HIV-1 Vif suppresses antiviral immunity by targeting STING. Cellular & molecular immunology. 2022 Jan;19(1):108-121

Mesh Tags

Substances

PMID: 34811497

search → result